ALPHARETTA, Ga.--(BUSINESS WIRE)--May 3, 2006--First Horizon Pharmaceutical Corporation (Nasdaq:FHRX - News), a specialty pharmaceutical company, today announced that it has completed its previously announced offer to exchange up to $150,000,000 aggregate principal amount of its New 1.75% Contingent Convertible Senior Subordinated Notes Due 2024 (the "New Notes") for an equal principal amount of its currently outstanding 1.75% Contingent Convertible Senior Subordinated Notes Due 2024 (the "Old Notes"). The exchange offer expired at 5:00 p.m., EDT, on May 2, 2006 (the "Expiration Date").
